Weight-loss jabs may have to be used for many years if the long-term benefits to patients and health care systems are to be realised, experts have said.The drugs are sold under brand names like ...

Sitting for long hours at a desk can be as harmful as smoking, increasing the risk of heart disease, diabetes, obesity, and ...

House of Delegates today passed the Endocrine Society's resolution to improve access to anti-obesity medications.

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

A new study published in the Obesity Journal found that anti-obesity injections may have a lesser impact on weight loss in a real-world context compared to clinical trials, as patients tend to ...

An intensive low-energy diet program, similar to the "NHS Type 2 Diabetes Path to Remission", significantly improved eating ...

Ozempic is a medication primarily approved for managing type 2 diabetes. Its active ingredient, semaglutide, mimics a hormone ...

(The Center Square) - Sen. Ruben Gallego, D-Arizona, announced his support for a bill aimed at helping America’s obesity ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...